Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

The conclusion is that tissue structure is key for stem cell communication and maintaining healthy tissues.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Hair growth can be induced by certain cells found at the base of hair follicles, and these cells may also influence hair development and regeneration.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

FOXN1 gene variants cause low T cells and immune issues from birth.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.